Doctors may soon be able to inject gene therapy intravenously that travels to a specific part of the body, according to a study published in today’s rapid access issue of Circulation: Journal of the American Heart Association.“It may be possible to design and construct genetically engineered ‘designer’ gene therapy for selectively delivering genes to any part of the body,” said Andrew H. Baker, Ph.D., lead investigator of the study and a reader in molecular medicine at the University of Glasgow in Scotland. “We can’t do that now because much of what’s injected would be sequestered by the liver.” The liver cleanses the blood of foreign material, among other functions.
